Every Issue
Note From the Hepatitis C Editor
We can’t get there without harm reduction
Briefly July + August 2024
Follow the research: TAG’s pipeline reports
Behind the cover: His life’s work
Peter McLoyd has made a life as a peer educator living with HIV and hepatitis
This Issue
Texas hold ’em
Advocates fight to get uninsured Texans access to Cabenuva
Removing the hurdles
Advocates California tries to ‘cleanup’ a law that was intended to improve PrEP access
Notes from Barcelona
Highlights from ESCMID Global 2024—the European Society of Clinical Microbiology and Infectious Diseases conference in Barcelona, Spain
The Global Picture: Advancing the conversation
In Nigeria, an advocate uses personal storytelling to share knowledge and strength
The language of HIV (de) criminalization
Choosing your words: Kamaria Laffrey, co-executive director of The SERO Project, talks about her strategy in the fight to modernize and repeal outdated laws that criminalize HIV
Hepatitis Drug Guide
Understanding your hepatitis C results
What do they mean? Andrew Reynolds, our hep C editor, explains
Hepatitis C reinfection: You mean I can get this again?
Everything you ever wanted to know about hepatitis reinfection
Hepatitis B—An overview
A cheat sheet from Andrew Reynolds on the most common infectious disease in the world
Hepatitis B medications
Preferred regimens based on AASLD treatment guidelines
Black Box Warning
Hepatitis B reactivation
HBV resources
Hepatitis B Medication Patient Assistance Programs
